Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Single Dose and Repeat Dose of GSK3342830 [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, and pharmacokinetics of ascending IV single and repeat doses of GSK3342830; the trial is terminated with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections Bacterial

Drugs mentioned

• GSK3342830

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Bacterial | Phase 1 | Status: TERMINATED | Results posted: 2018-09-12